J. Safra Sarasin Holding Ag Bristol Myers Squibb CO Transaction History
J. Safra Sarasin Holding Ag
- $5.76 Trillion
- Q3 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 36,473 shares of BMY stock, worth $2.18 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
36,473
Previous 857,672
95.75%
Holding current value
$2.18 Million
Previous $35.6 Billion
94.7%
% of portfolio
0.03%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,477Shares Held
1.51BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$11.2 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.49 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.47 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.66 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.65 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...